Re-appointment of Mr. Parth Chandulal Kothia as Whole-time Director of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Remedies' Board has approved the re-appointment of Mr. Parth Chandulal Kothia as Whole-time Director and Chief Financial Officer for a further 5 years, effective January 17, 2026 to January 16, 2031, subject to shareholder approval. Mr. Kothia is a Chemical Engineering graduate with an MSc in Global Finance from Fordham University, USA, and has been with the company since 2021. He holds 131,704 equity shares in the company. The filing confirms he is not debarred from holding office by any SEBI or regulatory authority.
This re-appointment ensures leadership continuity at the company. Notably, Mr. Kothia is the son of the Chairman and Managing Director, meaning the promoter family continues to hold key executive positions including the CFO role. The move is subject to member approval at the next general meeting.